Verified
High Ratings
80+ Specializations
210+ Therapies
Research Phase I/II/III

About Specializations

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw specializes in nuclear medicine and clinical trials in cancer, heart, lung, and immune diseases.

Medical Center localisation

Ul. Szaserow 128
04-141 Warsaw, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • Study of Lactobacillales and Lacidofil in Multiple Sclerosis Patients: Comparing Effectiveness of Probiotic Therapy

    Not yet recruiting

    2 1 1 1
    Poland
  • Study of Lutetium-177 and Yttrium-90 DOTATATE combination therapy for patients with inoperable gastrointestinal neuroendocrine tumors

    Not yet recruiting

    3 1 1
    Poland
  • Study of acetylsalicylic acid and clopidogrel treatment duration after left atrial appendage closure in patients with atrial fibrillation

    Not yet recruiting

    3 1 1 1 1
    Investigated Diseases:
    Poland
  • Study of acetylsalicylic acid and clopidogrel treatment after left atrial appendage closure in patients with atrial fibrillation and chronic kidney disease

    Not yet recruiting

    3 1 1 1 1
    Investigated Diseases:
    Poland
  • Study on Metformin’s Effect in Reducing Unplanned Heart Procedures in Non-Diabetic Patients with Acute Coronary Syndrome

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Poland
  • Study on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Poland Spain
  • Study on the Effects and Safety of Cemiplimab and BNT116 in Adults with Advanced Non-Small Cell Lung Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Germany Poland Spain
  • Phase 3 study of ianalumab plus standard drug combination in adults and adolescents with systemic lupus erythematosus

    Not recruiting

    3 1 1
    Investigated Diseases:
    Bulgaria Czechia Hungary Poland Portugal Slovakia +1
  • A study to evaluate the effectiveness and safety of tulisokibart and placebo in patients with moderate to severe ulcerative colitis

    Not recruiting

    3 1
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Finland +15
  • A study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation

    Not recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Bulgaria Croatia Czechia Denmark +18